カプセル充填機: 究極のガイド – 5 必須のタイプ, 主な特長 & 購入者のチェックリスト
9月 26, 2025
Scaling a capsule product from lab to commercial production requires systematic checks of formulation, カプセルシェル, filling process, 工程内制御, packaging and stability, and equipment qualification. Key factors include powder flow properties, fill weight and density, capsule material choice (ゼラチン vs HPMC), dosing technology and machine settings. A production-scale trial with the actual formulation is essential to confirm performance at target speed and fill weight. 品質管理 (capsule gross/net weight, シールの完全性, IPC charts) and suitable primary packaging (blister vs bottle with moisture/oxygen barriers) safeguard content uniformity and stability. ついに, define FAT/IQ/OQ/PQ protocols for the capsule filler, ensuring it meets your specs across speeds and produces consistent batches. Use the checklist below to guide your scale-up and work closely with your capsule-filling equipment supplier to de-risk the transfer to commercial production.
Capsule scale-up is the process of transferring a formulation and filling process from laboratory batches to pilot and full commercial production. It involves verifying that powder blend properties, 充填重量, dosing technology そして マシンの設定 can reliably meet product specifications at larger scale. FDAのガイダンス (SUPAC-IR) explicitly covers changes like manufacturing scale-up and equipment changes for 固体経口剤形. 実際に, scale-up means identifying critical process parameters (CPPs) and quality attributes (CQA) 開発中, and then confirming them in pilot and engineering runs before full production.
Key stages include:
Before full-scale production, review all aspects of your product and process. 要約すれば, ensure you:
Each of the above is explained in detail below. After reading, use the Actionable Scale-Up Checklist (at article’s end) to tick off each item.
Powder Flowability: Capsule fill accuracy depends on consistent powder flow. Characterize your blend using multiple metrics — there is no single “flow number”. 米国薬局 <1174> notes that powder flow is “multifaceted” and requires several tests. Measure bulk/tapped density (to compute Carr’s Index and Hausner Ratio) and simple indices like angle of repose as a first pass. Be alert that fine or cohesive powders may show variable behavior: adhesion and cohesion rise sharply at small particle sizes, and moisture-sensitive powders can cake or stick over time.
Bulk Density and Fill Volume: Always relate capsule weight (mg) to powder volume. Use the formula:
Required powder volume ≈ Target fill weight / Bulk density
例えば, a Size 0 ゼラチンカプセル (≈0.68 mL volume) needs about 0.408 g of a 0.60 g/mL bulk-density powder. If your target fill (例えば. 500 mg) exceeds this loose volume, anticipate that tamping pins or dosator compaction will be required. 要するに, calculate the volume versus capsule size for each formulation to ensure a feasible match. (If volume is tight, you may need a larger capsule or a more compactible formulation.)
粒子サイズ & 分離: Check particle size distribution of each component. Very fine particles can cause dusting and poor flow; broad size differences risk blend segregation during handling. Use sieve or laser sizing and verify blend homogeneity. For formulations with a very small (例えば. <50 µm) 成分, consider granulation or adding glidants.
水分 / Cohesion: Hygroscopic or sticky powders can cling to the hopper or dosing parts. Perform a short humidity stress test: expose a sample to expected processing RH and see if flow changes (固まる, 固まる). If moisture is a concern, plan for dehumidified feed hoppers or anti-static devices. Don’t rely on specs alone; small humidity changes can turn a free-flowing powder into a problematic one.
Confirm on-Target Dose: Make sure you know the exact target fill weight (mg) and desired capsule size. Record these clearly in your development and transfer documents. Bulk density variations between batches can affect the chosen capsule size, so confirm density and fill weight for at least 2–3 representative batches.
Choosing the capsule material and size is a critical scale-up decision. The table below compares ゼラチン そして HPMC ハードカプセル, the two most common shell types:
| 特徴 | ゼラチンカプセル | HPMC (Veggie) カプセル |
| 材料 | 動物性コラーゲン (ゼラチン) | ヒドロキシプロピルメチルセルロース (cellulose polymer) |
| Typical moisture content | 12-16% | ~4–7% |
| 湿気に敏感 | Sensitive – brittle if too dry, sticky if too wet | More stable – lower shell moisture keeps them less brittle |
| Dissolution speed | Dissolve quickly (traditionally preferred) | Slightly slower than gelatin (lacking protease enzymes) |
| Vegetarian/Allergen status | Not ベジタリアン (animal) | Vegan/vegetarian-friendly |
| 料金 | Generally lower cost | 適度 (usually higher than gelatin) |
| ユースケース | Widely used in pharma; okay for moisture-hardiness? | Preferred for moisture-sensitive or strict veg requirements |
| Regulatory monograph | Hard Gelatin Capsule Shells (USP/NF) | Hard Hypromellose (Vegetable) Capsule Shells (USP/NF) |
| Fill capacity vs. サイズ | All sizes available; high fill volume for given size | Similar range; large HPMC capsules are available |
重要なポイント: Gelatin is traditional and inexpensive, but it absorbs moisture from air and can become brittle or sticky with humidity changes. HPMC capsules contain much less water and are generally better for moisture-sensitive formulations. If your formulation is hygroscopic or moisture-sensitive, HPMC (ベジタリアン) capsules are often a safer starting point. 一方で, if cost is tight and moisture isn’t a problem, gelatin is acceptable for many products. (For special needs, プルラン or other veggie shells exist – pullulan, 例えば, has excellent oxygen-barrier properties, but this may be beyond initial scale-up scope.)
Also double-check capsule size vs. 充填重量: sizes 000–5 range from ~1.37 mL down to 0.13 mL. Use your powder’s bulk/tapped density to pick a capsule size that accommodates the full dose without excessive compression. ジンル capsule size guide provides capacity charts if needed.
ついに, verify shell dimensions and locking mechanism. Capsule suppliers maintain tight tolerances, but it’s good practice to sample and weigh empty shells (キャップ + 体) for consistency. Shell-to-shell weight variation can falsely appear as fill-weight drift. In operations, always use a tare weight or weight-based QC rather than relying on an average shell weight.
Capsule fillers come in different dosing mechanisms. The two main principles are tamping-disc (piston) filling and ディスペンサー (チューブ) 充填:
Neither system is categorically better. In comparative tests, dosators needed more compactible (凝集性のある) 粉末, while tamping-disc fillers were more forgiving to lubricated formulations. When scaling up, match your chosen filling machine’s mechanism to your powder properties: 例えば. if your blend is very free-flowing, a tamping machine may work well; if it’s sticky or very low-dose, consider a specialized dosator configuration. If switching machines (例えば. lab vs plant use different types), expect to re-optimize the formulation or lubrication.
ヒント:
Lab data alone cannot guarantee success at speed. Always run a real formulation trial on the intended capsule filling equipment. Use the actual production blend, target capsule shell and planned fill weight. Schedule time on a production or pilot-scale machine, ideally the model you plan to buy or a representative machine.
Trial steps:
1. 設定: Record everything—formulation batch ID, bulk/tapped density, カプセルタイプ & サイズ, 投与部品, initial hopper level and machine settings.
2. Low-speed trial: Start at a conservative speed to verify basic feeding: check that capsules separate, 埋める, lock properly, and there are no jams or bridging.
3. Normal-speed run: Increase to your planned operating speed (例えば. design output rate). Run for a fixed time or count (例えば. 1,000 カプセル), sampling capsules throughout.
4. High-speed test: ついに, test near the machine’s rated top speed (if required by your plan) to see if performance holds.
Measurements: At each speed step, measure at least 10–20 capsules at start, 真ん中と終わり. Record gross weight (カプセル + シェル) and empty-shell tare separately. Calculate net fill weight and its mean/variance. Note reject (underweight/overweight) counts and types (例えば. clear capsules vs dust). Also watch for issues: hopper bridging, powder dust escaping, カプセルの破損, inconsistent locks, 等. All these are recorded in a checklist or log.
例えば, one case study found that simply raising the fill speed on a dosator machine increased vibration, どれの densified the powder bed and significantly changed the average fill weight. 言い換えると, a short demo at low speed does not guarantee identical behavior at full speed.
Output calculation: Don’t just trust the rated speed (カプセル/時間) for planning output. Actual hourly output = (機械の速度) × (availability factor) × (good capsule yield). Expect some downtime (クリーニング, hopper refills, 拒否します). A simple planning equation is useful:
Effective output (カプセル/時間) ≈ Rated speed × 0.85 × Yield
(adjust 0.85 as a typical runtime efficiency, and yield as 1 – reject rate).
Use the trial to collect data for that calculation. 例えば, if the machine speed is 50,000 キャップ/時間, but you get 2% rejects and 90% 稼働時間, your effective output might be ~44,100 caps/hr. This informs equipment sizing for commercial production.
Implement inline and lab controls to catch issues early during scale-up batches:
Choosing the right primary packaging is essential for commercial capsules:
True shelf life depends on the whole system: 粉 + カプセル + パッケージング + ストレージ条件. Once packaging is chosen, prepare ICH stability samples (accelerated and long-term) in that final container-closure. Monitor critical attributes: 効力, 解散, 水分含有量, capsule integrity and any degradation products. If your product is moisture or oxidation sensitive, test with and without 乾燥剤 or oxygen absorbers to see their impact. 覚えて: the stability expiration date is for the finished product in its container, not the empty capsule shell alone. Stability outcomes may prompt adjustments in packaging (例えば. adding desiccant, using foil blisters) or even revisiting the shell material choice.
Before commercial batches, qualify your カプセル充填装置 and establish acceptance criteria:
Engage quality and engineering early. Remember FDA/EU regulations (GMP) expect you to validate and document the entire process. 業界のガイダンスによると, a successful scale-up aligns process parameters and QC protocols from the start so the program “scales without deviation”. Work with your equipment supplier to ensure design and validation plans are on track.
Use the following checklist when preparing for commercial capsule production. Check each item as it’s completed:
| ステップ & カテゴリ | Checklist Task |
| 定式化 | ☐ Confirm target dose and capsule size (calculate required fill volume) |
| ☐ Measure bulk & tapped densities (compute Carr’s Index, ハウスナー比) | |
| ☐ Test powder flow (安息角, shear cell or rheometry if needed) | |
| ☐ Evaluate particle size distribution and segregation risk | |
| ☐ Check moisture sensitivity / 吸湿性 (small-scale humidity test) | |
| ☐ Ensure blend homogeneity and API content uniformity | |
| Capsule Shell | ☐ Choose shell material (ゼラチン, HPMC, 等) based on moisture and regulatory needs |
| ☐ Confirm capsule dimensions, volume and weight consistency | |
| ☐ Verify capsule locking features and compatibility with fill | |
| ☐ Order and test sample capsules from the approved supplier | |
| 充填工程 | ☐ Select dosing mechanism (tamping pins/disc vs dosator) based on formulation properties |
| ☐ Install correct tooling (カプセルソーター, filling pins/discs, 等) | |
| ☐ Set preliminary machine parameters (スピード, tamp depth, feeder height, 等) | |
| ☐ Perform pilot runs: start at slow speed, then at planned speed | |
| ☐ Collect fill-weight data (ネット & gross) and calculate variability | |
| Machine Trial | ☐ Run full trial with actual formulation and capsule at low, normal and max speeds |
| ☐ Record speed vs output and note any bridging, dust or feed issues | |
| ☐ Calculate actual throughput (キャップ/時間) considering rejects | |
| ☐ Inspect filled capsules for filling, ロックする, および視覚的な欠陥 | |
| In-Process QC | ☐ Monitor capsule gross/net weight, fill-weight deviation and trend |
| ☐ Check weight variation against specifications (米国薬局 <905> 該当する場合) | |
| ☐ Implement capsule inspections (ロックする, 色, ダメージ) | |
| ☐ Conduct preliminary dissolution/content-uniformity tests on pilot samples | |
| 包装 & 安定性 | ☐ Choose primary packaging (水膨れ, ストリップ, or bottle) with proper barrier |
| ☐ Include desiccants or oxygen barriers if needed | |
| ☐ Plan and begin stability testing in final pack (ICH protocols) | |
| ☐ Test prototype batches for shelf-life (水分, 劣化) | |
| 機器の認定 | ☐ Define acceptance criteria (塗りつぶし精度, スピード, 拒否率, 等) |
| ☐ Execute FAT on capsule filler with placebo or actual product | |
| ☐ Complete IQ (installation checklists, 較正) | |
| ☐ Complete OQ (challenge speed range, アラーム, インターロック) | |
| ☐ Perform PQ (≥3 consecutive batches meeting specs) | |
| ドキュメント | ☐ Finalize batch record templates and tech-transfer SOPs |
| ☐ Compile FMEA / risk assessment and validation protocols | |
| ☐ Train operators and QA on process changes and controls |
If you’ve never used this capsule machine or this formulation on that equipment, plan a formal trial. Jinlu recommends: 「test the actual formulation on the proposed capsule filling equipment under realistic operating conditions」 to avoid surprises. This can be done as part of FAT with the supplier or as a dedicated R&D session. FAT中, insist on using your fill material, カプセル, and speed range. インストール後, execute Site Acceptance Testing (土) then IQ/OQ before any routine production. Engaging the equipment vendor early (for trial runs, custom tooling or software setup) can significantly de-risk the scale-up.
Scale-up is a team sport. Success requires collaboration between development (定式化), エンジニアリング (装置), quality and production teams. By following this checklist, you ensure no critical factor is missed. The process ultimately leads to 一貫性のある, high-quality capsules at commercial volumes.
Ready to scale up your capsule production? Jinlu’s experts can support every step—from powder trials to FAT. お問い合わせ to schedule a production-scale test of your formulation on our capsule filling machine. We provide FAT/IQ/OQ services and customized integration to help you reach commercial output smoothly.
Capsule manufacturing scale-up is the process of moving a capsule product from laboratory or pilot batches to commercial production while maintaining consistent formulation performance, 充填重量, 製品の品質, 安定性, 生産効率と.
Before scale-up, check powder flowability, bulk and tapped density, 粒径, 湿気への敏感性, capsule shell compatibility, 目標充填重量, カプセルサイズ, filling method, 機械の速度, 工程内制御, パッケージング, 安定性, and validation requirements.
多くの場合、そうです, but it should not be assumed automatically. A formulation that works well in a small batch may behave differently at higher production volumes because powder handling, ブレンドする, 振動, feeding conditions, 湿度, and capsule filling speed can change.
Powder flowability affects how consistently material enters the dosing area of a capsule filler. Poor or unstable flow can cause bridging, inconsistent feeding, 充填重量の変動, dust generation, and reduced production speed. Flow should therefore be evaluated before commercial-scale filling.
Start with the target dose, powder bulk density, required fill volume, and the filling method. The selected capsule should provide enough usable volume without requiring excessive powder compression. A production-scale filling trial is recommended before the capsule size is finalized.
The choice depends on the formulation, 湿気への敏感性, storage environment, regulatory or dietary requirements, and packaging system. Gelatin capsules are widely used, while HPMC capsules are often considered for formulations that require lower shell moisture or plant-based materials.
Higher machine speed can change powder feeding, powder-bed density, 振動, 滞在時間, and dosing behavior. このため, stable fill weight at low speed does not automatically prove that the process will remain stable at normal or maximum production speed.
はい, especially for cohesive, 吸湿性の, low-density, high-dose, or otherwise difficult formulations. A real machine trial using the actual powder, カプセルシェル, 目標充填重量, and planned production speed helps verify dosing accuracy, 出力, 拒否率, and process stability.
Neither format is universally better. Blisters are often selected when individual-dose protection and strong moisture barriers are important, while bottles are efficient for larger counts and high-volume production. The final choice should be based on stability data, バリア要件, market needs, and production capacity.
The safest approach is to treat scale-up as a controlled process rather than simply increasing machine speed. Characterize the formulation, confirm capsule-shell compatibility, establish filling parameters through trials, monitor fill-weight consistency, verify equipment capacity and make sure downstream packaging can match production output. Document the approved process conditions and investigate deviations before full commercial production.
参考文献：
1.ゼラチンの吸放湿特性, HPMCとプルランハードカプセル —— パブメッド
2.TECHNICAL AND REGULATORY CONSIDERATIONS FOR PHARMACEUTICAL PRODUCT LIFECYCLE MANAGEMENT —— ICH Q12
3.ユードラレックス – 音量 4 – 優れた製造業 (GMP) ガイドライン —— 欧州委員会
4.粉末流動特性がカプセル充填重量の均一性に及ぼす影響 —— パブメッド
5.Moisture diffusion and permeability characteristics of hydroxypropylmethylcellulose and hard gelatin capsules —— パブメッド
6.プロセスの検証: General Principles and Practices —— FDA
ペティフー, 金魯包装の創設者, もたらす 20 製薬機械分野における長年の専門知識. 彼のリーダーシップの下で, Jinlu はデザインを統合する信頼できるサプライヤーに成長しました, 生産, と販売. ペティは、クライアントが医薬品包装の複雑さを乗り越えられるよう、業界の深い知識を共有することに情熱を持っています。, 機器だけでなく確実に受け取れるようにする, しかし、生産目標に合わせて調整された真のワンストップ サービス パートナーシップ.
